1. Please indicate if the following objectives were achieved.

Question Title

* After attending this symposium, I am able to:

  Disagree Neutral Agree
Assess the role of patient-reported outcomes (PROs) in treat-to-target (T2T) goals for spondyloarthropathy (SpA) patients
Discuss optimal approaches to incorporate patient treatment goals and PROs in SpA T2T management plans through shared decision-making, while taking into consideration individual patient characteristics
Describe the impact of targeted therapies on PROs in SpA

Question Title

* If you answered “Disagree”, or “Neutral” please explain what content was missing or could be improved to better achieve the above-stated objectives:

Question Title

* 2. Please rank the level of importance you assign to the following factors when deciding on a treatment option for your SpA patients (1 being the most important).

Question Title

* Other:

Question Title

* 3. For the purpose of the following questions, bias is defined as “A personal judgment in favour of a specific proprietary business interest or a commercial interest.”

  Yes No
Was the symposium presentation scientifically valid and balanced?
Was the symposium free from indicators of undue industry bias?
Was the symposium free from indicators of undue personal/other bias?

Question Title

* 4. If you answered “No” to any of the above, what was the bias that was detected? Please provide example(s).

Question Title

* 5. Please state an important concept or information that you have learned from the session.

Question Title

* 6. Would you recommend this session to your colleagues?

Question Title

* Please state the reason(s) why you would or would not recommend this session to a colleague.

Question Title

* 7. Please provide your general comments, suggestions for topics, or additional recommendations to improve future sessions:

T